Select Language:
The U.S. embassy in New Delhi announced on Thursday that it has revoked and denied visas to certain Indian business executives and corporate leaders due to their alleged involvement in trafficking fentanyl precursors. The statement clarified that these individuals are Indian nationals, though their identities were not disclosed.
Fentanyl precursors are the fundamental chemicals used to produce fentanyl, which has become a leading cause of overdose deaths in the United States.
The embassy emphasized that Indian officials are collaborating closely with U.S. authorities to address the ongoing challenge of drug trafficking.
India’s foreign ministry has not responded immediately to a Reuters request for comment regarding the U.S. visa actions.
U.S. President Donald Trump, whose previous tariffs of 50% on Indian imports strained bilateral relations, has also imposed additional tariffs on imports from China, Mexico, and Canada. He has stated these measures aim to curb the flow of fentanyl into the U.S.
In a Congressional briefing this week, Trump identified India as one of 23 major transit or manufacturing countries for illegal drugs, though he noted that listing a country does not necessarily reflect its government’s efforts in combating drug trafficking.
Add us on ChatGPT
Add us on Perplexity
